(CDC) VictoryShares US EQ Income - Ratings and Ratios
Large-Cap,High-Dividend,Equity,Weighted,Vola
Dividends
| Dividend Yield | 3.36% |
| Yield on Cost 5y | 4.94% |
| Yield CAGR 5y | 11.66% |
| Payout Consistency | 97.3% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 9.71% |
| Value at Risk 5%th | 16.4% |
| Relative Tail Risk | 2.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.41 |
| Alpha | -1.01 |
| CAGR/Max DD | 0.46 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.394 |
| Beta | 0.504 |
| Beta Downside | 0.611 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.66% |
| Mean DD | 5.68% |
| Median DD | 5.18% |
Description: CDC VictoryShares US EQ Income October 22, 2025
The VictoryShares US EQ Income Enhanced Volatility Weighted ETF (NASDAQ: CDC) aims to track at least 80 % of the Nasdaq Victory U.S. Large Cap 100 High-Dividend Long/Cash Volatility Weighted Index, which selects the 100 highest-yielding stocks from the broader Nasdaq Victory U.S. Large Cap 500 Volatility Weighted universe. In practice, the fund holds a concentrated basket of large-cap U.S. equities that combine strong dividend payouts with lower price volatility.
Key metrics (as of the most recent filing) include an expense ratio of roughly 0.35 % and a 30-day SEC yield near 4.2 %, placing CDC among the higher-yielding large-value ETFs. Sector allocation is typically weighted toward utilities, consumer staples, and real-estate investment trusts-industries that historically offer stable cash flows and are less sensitive to short-term market swings. Because the index is volatility-weighted, CDC’s exposure to high-beta tech stocks is trimmed, making the fund’s performance more correlated with interest-rate environments; rising rates can pressure dividend-heavy sectors, while a flattening yield curve often supports their valuations.
If you want a deeper, data-driven view of CDC’s risk-adjusted returns and how its volatility-weighting compares to traditional dividend ETFs, ValueRay’s analytics platform provides the granular tools you need to continue the investigation.
What is the price of CDC shares?
Over the past week, the price has changed by -0.04%, over one month by +1.03%, over three months by +1.16% and over the past year by +9.36%.
Is CDC a buy, sell or hold?
What are the forecasts/targets for the CDC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 71 | 7.6% |
CDC Fundamental Data Overview December 22, 2025
Beta = 0.46
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 702.0m USD (702.0m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 702.0m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 702.0m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.87% (E(702.0m)/V(702.0m) * Re(7.87%) + (debt-free company))
Discount Rate = 7.87% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CDC ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle